Literature DB >> 29515253

Clinical-scale manufacturing of γδ T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis.

Lawrence S Lamb1, Sailesh Pillai2, Samantha Langford2, Joscelyn Bowersock2, Antonio Di Stasi2, Ayman Saad2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29515253     DOI: 10.1038/s41409-018-0130-8

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  5 in total

Review 1.  T cell optimization for graft-versus-leukemia responses.

Authors:  Melinda A Biernacki; Vipul S Sheth; Marie Bleakley
Journal:  JCI Insight       Date:  2020-05-07

Review 2.  CAR γδ T cells for cancer immunotherapy. Is the field more yellow than green?

Authors:  Thamizhselvi Ganapathy; Rajalingam Radhakrishnan; Seth Sakshi; Sunil Martin
Journal:  Cancer Immunol Immunother       Date:  2022-08-12       Impact factor: 6.630

Review 3.  Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma.

Authors:  Barbara Castella; Assunta Melaccio; Myriam Foglietta; Chiara Riganti; Massimo Massaia
Journal:  Front Oncol       Date:  2018-11-06       Impact factor: 6.244

Review 4.  Boosting the Immune System for HIV Cure: A γδ T Cell Perspective.

Authors:  Brendan T Mann; Edward Sambrano; Sanjay B Maggirwar; Natalia Soriano-Sarabia
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 6.073

5.  Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.

Authors:  Lia Minculescu; Hanne Vibeke Marquart; Lars Peter Ryder; Niels Smedegaard Andersen; Ida Schjoedt; Lone Smidstrup Friis; Brian Thomas Kornblit; Søren Lykke Petersen; Eva Haastrup; Anne Fischer-Nielsen; Joanne Reekie; Henrik Sengelov
Journal:  Front Immunol       Date:  2019-08-22       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.